Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 3c, provides guidance

Go back to Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 3c, provides guidance
(NASDAQ: XERS) Delayed: 7.20 +0.30 (4.35%)
Previous Close $6.90    52 Week High
Open $6.90    52 Week Low
Day High $7.30    P/E N/A 
Day Low $6.86    EPS
Volume 1,978,920